May, F;Guenther, M;Fastenmeier, K;Hartung, RImproved high-frequency surgery for transurethral resection of the prostate: Report from a multicenter trial and identification of risk groupsJ Urol2003169 Suppl.4467-467
Paul, R;Pfeifer, A;van Randenborgh, H;Kubler, H;Hartung, RRenal cell cancer: Is there a true difference in prognosis of papillary and clear cell type carcinomas?J Urol2003169 Suppl.4262-262
Weller, D;May, F;Rowett, D;Esterman, A;Pinnock, C;Nicholson, S;Doust, J;Silagy, CPromoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout.Fam Pract2003206655-61
Barba, M;Fastenmeier, K;Hartung, RElectrocautery: principles and practice.J Endourol2003178541-55
May, F;Treiber, U;Hartung, R;Schwaibold, HSignificance of random bladder biopsies in superficial bladder cancer.Eur Urol200344147-50
Treiber, U;Schwaibold, H;Berger, H;Hartung, R[Pseudoaneurysm of a subsegmental renal artery after percutaneous nephrolitholapaxy]Urologe A2003424547-52
Weirich, G;Nährig, J;Treiber, U;Hartmann, C;Hartung, R;Höfler, H;Fend, FImmunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approach.Appl Immunohistochem Mol Morphol200311196-100
Heit, A;Maurer, T;Hochrein, H;Bauer, S;Huster, KM;Busch, DH;Wagner, HCutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.J Immunol200317062802-5
Gerhard, MC;Zantl, N;Weirich, G;Schliep, S;Seiffert, B;Häcker, GFunctional evaluation of the apoptosome in renal cell carcinoma.Br J Cancer200389112147-54
Hartwig, SE;Faustel, R;Weirich, G;Treiber, U;Wagenpfeil, S;Hartung, ROver-expression of HER2/NEU correlates with tumor-specific survival of patients with urothelial carcinoma of the bladderJ Urol2003169 Suppl.4136-136
Login
